よむ、つかう、まなぶ。
【参考資料4】抗微生物薬適正使用の手引き 第三版 本編 (58 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
| 出典情報 | 厚生科学審議会 感染症部会 薬剤耐性（AMR）に関する小委員会 抗微生物薬適正使用（AMS）等に関する作業部会（第6回 11／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第三版
102. 国立感染症研究所, 厚生労働省健康局結核感染症課. ロタウイルス胃腸炎の発生動向とワクチ
ン導入後の報告数の推移. 病原微生物検出情報. 2015;36(7):145-146.
103. 国立感染症研究所ホームページより,
https://www.niid.go.jp/niid/ja/allarticles/surveillance/2270-idwr/nenpou/11638syulist2021.html. 最終閲覧日 2023 年 9 月 25 日.
104. Cohen SH, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile
Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America
(SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp
Epidemiol. 2010;31(5):431-455.
105. Beeching N, Gill G. Lecture Notes: Tropical Medicine. 7th edition. West Sussex: WileyBlackwell; 2014.
106. DuPont HL. Acute infectious diarrhea in immunocompetent adults. N Engl J Med.
2014;370(16):1532-1540.
107. Scorza K, Williams A, Phillips JD, Shaw J. Evaluation of nausea and vomiting. Am Fam
Physician. 2007;76(1):76-84.
108. Fontanarosa PB, Kaeberlein FJ, Gerson LW, Thomson RB. Difficulty in predicting bacteremia
in elderly emergency patients. Ann Emerg Med. 1992;21(7):842-848.
109. Felton JM, Harries AD, Beeching NJ, Rogerson SJ, Nye FJ. Acute gastroenteritis: the need
to remember alternative diagnoses. Postgrad Med J. 1990;66(782):1037-1039.
110. Kollaritsch H, Paulke-Korinek M, Wiedermann U. Traveler’s Diarrhea. Infect Dis Clin North
Am. 2012;26(3):691-706.
111. Vernacchio L, Vezina RM, Mitchell AA, Lesko SM, Plaut AG, Acheson DWK. Diarrhea in
American infants and young children in the community setting: incidence, clinical
presentation and microbiology. Pediatr Infect Dis J. 2006;25(1):2-7.
112. King CK, Glass R, Bresee JS, Duggan C, Centers for Disease Control and Prevention.
Managing acute gastroenteritis among children: oral rehydration, maintenance, and
nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16.
113. Talan D, Moran GJ, Newdow M, et al. Etiology of bloody diarrhea among patients presenting
to United States emergency departments: prevalence of Escherichia coli O157:H7 and other
enteropathogens. Clin Infect Dis. 2001;32(4):573-580.
114. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases,
Centers for Disease Control and Prevention. Updated norovirus outbreak management and
disease prevention guidelines. MMWR Recomm Rep. 2011;60(RR-3):1-18.
115. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med.
2009;361(18):1776-1785.
116. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a
prospective cohort study. Clin Infect Dis. 2002;35(3):246-253.
117. Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DWG. Clinical manifestation of
norovirus gastroenteritis in health care settings. Clin Infect Dis. 2004;39(3):318-324.
118. 田中智之. ノロウイルス抗原迅速診断薬クイックナビ TM-ノロ 2 の評価. 医学と薬学.
2012;68(6):1033-1039.
58
第三版
102. 国立感染症研究所, 厚生労働省健康局結核感染症課. ロタウイルス胃腸炎の発生動向とワクチ
ン導入後の報告数の推移. 病原微生物検出情報. 2015;36(7):145-146.
103. 国立感染症研究所ホームページより,
https://www.niid.go.jp/niid/ja/allarticles/surveillance/2270-idwr/nenpou/11638syulist2021.html. 最終閲覧日 2023 年 9 月 25 日.
104. Cohen SH, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile
Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America
(SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp
Epidemiol. 2010;31(5):431-455.
105. Beeching N, Gill G. Lecture Notes: Tropical Medicine. 7th edition. West Sussex: WileyBlackwell; 2014.
106. DuPont HL. Acute infectious diarrhea in immunocompetent adults. N Engl J Med.
2014;370(16):1532-1540.
107. Scorza K, Williams A, Phillips JD, Shaw J. Evaluation of nausea and vomiting. Am Fam
Physician. 2007;76(1):76-84.
108. Fontanarosa PB, Kaeberlein FJ, Gerson LW, Thomson RB. Difficulty in predicting bacteremia
in elderly emergency patients. Ann Emerg Med. 1992;21(7):842-848.
109. Felton JM, Harries AD, Beeching NJ, Rogerson SJ, Nye FJ. Acute gastroenteritis: the need
to remember alternative diagnoses. Postgrad Med J. 1990;66(782):1037-1039.
110. Kollaritsch H, Paulke-Korinek M, Wiedermann U. Traveler’s Diarrhea. Infect Dis Clin North
Am. 2012;26(3):691-706.
111. Vernacchio L, Vezina RM, Mitchell AA, Lesko SM, Plaut AG, Acheson DWK. Diarrhea in
American infants and young children in the community setting: incidence, clinical
presentation and microbiology. Pediatr Infect Dis J. 2006;25(1):2-7.
112. King CK, Glass R, Bresee JS, Duggan C, Centers for Disease Control and Prevention.
Managing acute gastroenteritis among children: oral rehydration, maintenance, and
nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1-16.
113. Talan D, Moran GJ, Newdow M, et al. Etiology of bloody diarrhea among patients presenting
to United States emergency departments: prevalence of Escherichia coli O157:H7 and other
enteropathogens. Clin Infect Dis. 2001;32(4):573-580.
114. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases,
Centers for Disease Control and Prevention. Updated norovirus outbreak management and
disease prevention guidelines. MMWR Recomm Rep. 2011;60(RR-3):1-18.
115. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med.
2009;361(18):1776-1785.
116. Rockx B, De Wit M, Vennema H, et al. Natural history of human calicivirus infection: a
prospective cohort study. Clin Infect Dis. 2002;35(3):246-253.
117. Lopman BA, Reacher MH, Vipond IB, Sarangi J, Brown DWG. Clinical manifestation of
norovirus gastroenteritis in health care settings. Clin Infect Dis. 2004;39(3):318-324.
118. 田中智之. ノロウイルス抗原迅速診断薬クイックナビ TM-ノロ 2 の評価. 医学と薬学.
2012;68(6):1033-1039.
58